Abstract | BACKGROUND & AIMS: METHODS: We conducted a randomized, double-blind, placebo-controlled trial of swallowed FP in pediatric patients with active eosinophilic esophagitis. Thirty-six patients were randomly assigned to receive either 880 mug of FP (21 patients) or placebo (15 patients) divided twice daily for 3 months. The primary end point was histologic remission, defined by a peak eosinophil count of </=1 eosinophil in all 400x fields in both the proximal and distal esophagus. RESULTS: Fifty percent of FP-treated patients achieved histologic remission compared with 9% of patients receiving placebo (P = .047). FP decreased esophageal eosinophil levels, with a more pronounced effect in nonallergic individuals (65.9 +/- 25.3 vs 1.4 +/- 1.1 eosinophils/high-power field in the proximal esophagus [P = .03] and 84.6 +/- 19.7 vs 19.6 +/- 12.9 eosinophils/high-power field in the distal esophagus [P = .04]). Resolution of vomiting occurred more frequently with FP than placebo (67% vs 27%; P = .04). FP-induced resolution of mucosal eosinophilia was associated with resolution of endoscopic findings, epithelial hyperplasia, younger age (P = .0003), shorter height (P = .002), and lighter weight (P = .02). Effective treatment with FP decreased the number of CD8(+) T lymphocytes and mast cells in both the proximal and distal esophagus (P < .05). CONCLUSIONS: Swallowed FP is effective in inducing histologic remission in eosinophilic esophagitis, with a more pronounced effect in nonallergic and younger individuals, especially in the proximal esophagus.
|
Authors | Michael R Konikoff, Richard J Noel, Carine Blanchard, Cassie Kirby, Sean C Jameson, Bridget K Buckmeier, Rachel Akers, Mitchell B Cohen, Margaret H Collins, Amal H Assa'ad, Seema S Aceves, Philip E Putnam, Marc E Rothenberg |
Journal | Gastroenterology
(Gastroenterology)
Vol. 131
Issue 5
Pg. 1381-91
(Nov 2006)
ISSN: 0016-5085 [Print] United States |
PMID | 17101314
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Androstadienes
- Fluticasone
|
Topics |
- Adolescent
- Age Factors
- Androstadienes
(therapeutic use)
- Body Height
- Body Weight
- CD8-Positive T-Lymphocytes
(immunology)
- Child
- Child, Preschool
- Double-Blind Method
- Eosinophilia
(drug therapy, immunology, pathology)
- Esophagitis
(drug therapy, immunology, pathology)
- Female
- Fluticasone
- Humans
- Hyperplasia
- Infant
- Male
|